Advertisement

Sunshine Heart shares close up just shy of 14% on news of CE Mark approval for its C-Pulse outside-the-bloodstream heart pump in the European Union.

MassDevice.com Wall Street Beat

Sunshine Heart (ASX:SHC) is shining on Wall Street today after announcing European regulatory approval for its C-Pulse heart assist system, with SHC shares closing up nearly 14% on the news.

The Eden Prairie, Minn., and Sydney-based medical device company said the CE Mark means the C-Pulse system can be marketed for treating Class III and Class IV heart failure in the European Union and other countries that recognize the mark.

News of the approval for the C-Pulse outside-the-bloodstream heart pump sent SHC shares to $11.44 today, up 13.9%.

Advertisement
Advertisement